Means +/- standard errors of patient satisfaction with anticoagulant therapy measured by the Anti-Clot Treatment Scale (ACTS) over time.

<p>* p < 0.05, ** p<0.01, *** p < 0.001, Wilcoxon rank-sum test comparing baseline ACTS at baseline and ACTS after 1, 3 and 6 months for burden and benefit ACTS subscales separately.</p

Continuation rate with rivaroxaban treatment over time.

<p>Continuation rate with rivaroxaban treatment over time.</p

Demographic data and risk factors.

<p>Demographic data and risk factors.</p

Characteristics of patients according to low-quality control of INR (n = 2164).

<p>Characteristics of patients according to low-quality control of INR (n = 2164).</p

Uni- and multivariate logistic regression models showing the association between low-quality control of INR and Charlson Comorbidity Index ≥ 3 adjusted for clinical characteristics (n = 2164).

<p>Uni- and multivariate logistic regression models showing the association between low-quality control of INR and Charlson Comorbidity Index ≥ 3 adjusted for clinical characteristics (n = 2164).</p

Adherence to treatment over time.

<p>Adherence to treatment over time.</p

Association Between Hypoglycemia and the Burden of Comorbidities in Hospitalized Vulnerable Older Diabetic Patients: A Cross-Sectional, Population-Based Study

<p><strong>Article full text</strong></p> <p><br> The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s13300-017-0319-7"><b>here</b>.</a><br> <br> <strong>Provide enhanced content for this article</strong><br> If you are an author of this publication and would like to provide additional enhanced content for your article then please contact <u>[email protected]</u>.<br> <br> The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.<br> <br> Other enhanced features include, but are not limited to:<br> • Slide decks<br> • Videos and animations<br> • Audio abstracts<br> • Audio slides</p> <p> </p> <p> </p> <p> </p

Comparison of CEP and sub-scores according to age groups among 1991-and 2008-samples separately.

*<p>T-test;</p>†<p>T-tests stratified on gender and educational level; Mean (Standard Deviation); MMSE, Mini-Mental State Examination; CEP, Cognitive Efficiency Profile.</p

Comparison between participants < 80 yo and participants ≥ 80 yo. in the 1991-sample (a) and in the 2008-sample (b).

<p>Comparison between participants < 80 yo and participants ≥ 80 yo. in the 1991-sample (a) and in the 2008-sample (b).</p

Comparison according to age and birth date in the 1991-and 2008-samples.

<p>Comparison according to age and birth date in the 1991-and 2008-samples.</p